Correlation between inflammatory factors and post-stroke pneumonia in diabetic patients

Zhang,Hongming; Li,Xiaoyan

doi:10.3892/etm.2013.1103

Correlation between inflammatory factors and post-stroke pneumonia in diabetic patients

Authors:
- Hongming Zhang
- Xiaoyan Li
View Affiliations

Affiliations: Department of Cardiology, The General Hospital of Jinan Military Region, Jinan, Shandong 250031, P.R. China
Published online on: May 8, 2013 https://doi.org/10.3892/etm.2013.1103
Pages: 105-108

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pneumonia is the most common cause of mortality in stroke patients and it has been demonstrated to contribute to mortality and poor functional outcome following stroke in the majority of clinical studies. The risk of infection may be attributed to stroke‑induced immunodepression syndrome (SIDS). Cytokine production is increased in SIDS. However, the correlation between biomarkers and the risk of post‑stroke pneumonia in patients with diabetes mellitus is not clear. The aim of this study was to determine the correlation between pneumonia and the levels of C-reactive protein (CRP) and interleukin-6 (IL-6), as well as to identify early predictors of pneumonia in acute ischemic stroke patients with diabetes mellitus. Additionally, we investigated the impact of pneumonia on functional outcome after 1 month. A total of 106 ischemic stroke patients with diabetes mellitus who were admitted after the onset of symptoms were included in the study. They were divided into two groups, the pneumonia and non-pneumonia groups. CRP, IL-6, white blood cells (WBCs), mean body temperature and National Institutes of Health Stroke Scale (NIHSS) score were measured at the time of admission. The modified Rankin Scale score was assessed at 30 days. The levels of IL-6, CRP and WBCs, as well as mean body temperature were significantly higher in the patients with pneumonia than in the patients without pneumonia. There were also significant differences between the pneumonia and non-pneumonia groups in age, admission NIHSS score, length of hospital stay and dysphagia. Pneumonia patients had worse outcomes compared with patients without pneumonia at 1 month. Age, NIHSS score and dysphagia were significantly associated with pneumonia. WBCs and mean body temperature were not significant predictors of pneumonia. Older patients with more severe ischemic stroke are more susceptible to the development of pneumonia during the stay in hospital. Pneumonia contributes to poor functional outcome. IL-6, CRP, age, NIHSS score and dysphagia may predict the occurrence of pneumonia on the day of stroke symptom onset.

View Figures

View References

1.	Hong KS, Kang DW, Koo JS, et al: Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol. 15:1324–1331. 2008. View Article : Google Scholar : PubMed/NCBI
2.	Johnston KC, Li JY, Lyden PD, et al; RANTTAS Investigators: Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. Stroke. 29:447–453. 1998. View Article : Google Scholar : PubMed/NCBI
3.	Katzan IL, Cebul RD, Husak SH, Dawson NV and Baker DW: The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 60:620–625. 2003. View Article : Google Scholar : PubMed/NCBI
4.	Langhorne P, Stott DJ, Robertson L, et al: Medical complications after stroke: a multicenter study. Stroke. 31:1223–1229. 2000. View Article : Google Scholar : PubMed/NCBI
5.	Ovbiagele B, Hills NK, Saver JL and Johnston SC; California Acute Stroke Prototype Registry Investigators: Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis. 15:209–213. 2006. View Article : Google Scholar : PubMed/NCBI
6.	Tirschwell DL, Kukull WA and Longstreth WT Jr: Medical complications of ischemic stroke and length of hospital stay: experience in Seattle, Washington. J Stroke Cerebrovasc Dis. 8:336–343. 1999. View Article : Google Scholar : PubMed/NCBI
7.	Davenport RJ, Dennis MS, Wellwood I and Warlow CP: Complications after acute stroke. Stroke. 27:415–420. 1996. View Article : Google Scholar
8.	Sellars C, Bowie L, Bagg J, et al: Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke. 38:2284–2291. 2007. View Article : Google Scholar : PubMed/NCBI
9.	Dirnagl U, Klehmet J, Braun JS, et al: Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 38(Suppl 2): 770–773. 2007. View Article : Google Scholar : PubMed/NCBI
10.	Chamorro A, Urra X and Planas AM: Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke. 38:1097–1103. 2007. View Article : Google Scholar : PubMed/NCBI
11.	Gonsalves MD and Sakr Y: Early identification of sepsis. Curr Infect Dis Rep. 12:329–335. 2010. View Article : Google Scholar : PubMed/NCBI
12.	No authors listed:. Stroke - 1989. Recommendations on stroke prevention, diagnosis, and therapy Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders Stroke. 20:1407–1431. 1989.
13.	Mann G, Hankey GJ and Cameron D: Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke. 30:744–748. 1999. View Article : Google Scholar : PubMed/NCBI
14.	Vermeij FH, Scholte op Reimer WJ and de Man P; Netherlands Stroke Survey Investigators: Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis. 27:465–471. 2009. View Article : Google Scholar
15.	Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al; German Stroke Registers Study Group: Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med. 164:1761–1768. 2004. View Article : Google Scholar : PubMed/NCBI
16.	Hilker R, Poetter C, Findeisen N, et al: Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 34:975–981. 2003. View Article : Google Scholar : PubMed/NCBI
17.	Walter U, Knoblich R, Steinhagen V, Donat M, Benecke R and Kloth A: Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol. 254:1323–1329. 2007. View Article : Google Scholar : PubMed/NCBI
18.	Kammersgaard LP, Jørgensen HS, Reith J, et al: Early infection and prognosis after acute stroke: the Copenhagen Stroke Study. J Stroke Cerebrovasc Dis. 10:217–221. 2001. View Article : Google Scholar : PubMed/NCBI
19.	Hamidon BB, Raymond AA, Norlinah MI and Jefferelli SB: The predictors of early infection after an acute ischaemic stroke. Singapore Med J. 44:344–346. 2003.PubMed/NCBI
20.	Pittock SJ, Meldrum D, Hardiman O, Thornton J, Brennan P and Moroney JT: The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis. 12:1–7. 2003. View Article : Google Scholar
21.	Kwan J and Hand P: Infection after acute stroke is associated with poor short-term outcome. Acta Neurol Scand. 115:331–338. 2007. View Article : Google Scholar : PubMed/NCBI
22.	Vargas M, Horcajada JP, Obach V, et al: Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke. 37:461–465. 2006. View Article : Google Scholar : PubMed/NCBI
23.	Emsley HC: Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 7:341–353. 2008. View Article : Google Scholar : PubMed/NCBI
24.	Chamorro A, Amaro S, Vargas M, et al: Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry. 77:1279–1281. 2006. View Article : Google Scholar : PubMed/NCBI
25.	Hug A, Dalpke A, Wieczorek N, et al: Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke. 40:3226–3232. 2009.PubMed/NCBI
26.	Liesz A, Hagmann S, Zschoche C, et al: The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke. 40:2849–2858. 2009. View Article : Google Scholar : PubMed/NCBI
27.	Chamorro A, Amaro S, Vargas M, et al: Catecholamines, infection, and death in acute ischemic stroke. J Neurolog Sci. 252:29–35. 2007. View Article : Google Scholar : PubMed/NCBI
28.	Schwarz S, Al-Shajlawi F, Sick C, Meairs S and Hennerici MG: Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS). Stroke. 39:1220–1227. 2008. View Article : Google Scholar : PubMed/NCBI
29.	Harms H, Prass K, Meisel C, Klehmet J, et al: Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One. 3:e21582008. View Article : Google Scholar : PubMed/NCBI
30.	Chamorro A, Horcajada JP, Obach V, Vargas M, et al: The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke. 36:1495–1500. 2005. View Article : Google Scholar : PubMed/NCBI
31.	Lampl Y, Boaz M, Gilad R, et al: Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology. 69:1404–1410. 2007. View Article : Google Scholar : PubMed/NCBI